Clinical Trials on Chronic Opioid Use

Total 38047 results

University of Delaware
National Institute on Drug Abuse (NIDA); Brandywine Counseling and Community...

Recruiting

Disclosure Intervention for People in Treatment for Opioid Use Disorder

Opioid Use Disorder

United States
Brigham and Women's Hospital
University of Utah

Not yet recruiting

Extended-release Buprenorphine as a Novel Low-dose Induction Strategy

Opioid Use Disorder
Butler Hospital
National Institute on Drug Abuse (NIDA)

Recruiting

tDCS to Decrease Opioid Relapse (UH3)

Opioid Use Disorder

United States
Prisma Health-Upstate
National Institute on Drug Abuse (NIDA); Clemson University

Recruiting

Development, Refinement, and Validation of a Peer Support Specialist Checklist for Individuals With Opioid Use Disorder / STAMPS: South Carolina Buprenorphine Treatment Initiation, Adherence, and Retention Utilizing Mobile Health Units and Peer Support Specialists

Opioid Use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use (ROLDI)

Opioid Use Disorder
Friends Research Institute, Inc.

Not yet recruiting

Buprenorphine for Individuals in Jail

Opioid Use Disorder

United States
University of Colorado, Denver
National Institute on Drug Abuse (NIDA)

Recruiting

A Multi-site Intervention to Expand Hospital Based OUD Treatment Provision

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Assessing Optimal XRB Initiation Points in Jail

Opioid Use Disorder

United States
University Hospital, Strasbourg, France

Recruiting

Biopsychosocial Markers of Addiction in Opioid Users: an Integrated Approach (BEBOP)

Opioid Use Disorder

France
Friends Research Institute, Inc.
MATClinics

Recruiting

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Opioid Use Disorder

United States
Pouya Azar

Recruiting

Symptom-inhibited Fentanyl Induction (SIFI)

Opioid Use Disorder

Canada
University of Kentucky
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Cannabis and Opioid Use Disorder

Opioid Use Disorder
Gazi University

Recruiting

Investigation of the Relationship Between Different Assesments in Individuals in Opioid Maintenance Treatment Process

Opioid Use Disorder

Turkey
University of Pennsylvania

Recruiting

Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); Aptinyx

Recruiting

Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study

Opioid Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Recruiting

Evaluation of the Interactions of Cannabidiol (CBD) With Morphine

Opioid Use Disorder

United States
VA Office of Research and Development

Recruiting

A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder (VA-BRAVE)

Opioid Use Disorder

United States
Philadelphia College of Osteopathic Medicine
Prevention Point Philadelphia

Active, not recruiting

Therapy for People With Opioid Use Disorder

Opioid Use Disorder

United States
AstraZeneca

Completed

A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.

Opioid Use Disorder

United States
Center for Social Innovation, Massachusetts
West Haven VA

Completed

Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment (OASIS)

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Withdrawn

Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Opioid Use Disorder

United States
3D Therapy, LLC

Completed

The Feasibility of VR for OUD

Opioid Use Disorder

United States
Johns Hopkins University

Withdrawn

Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use

Opioid Use Disorder
Masimo Corporation

Enrolling by invitation

Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Opioid Use Disorder

United States
Carilion Clinic

Completed

START NOW in the Treatment of Opioid Addicted Individuals

Opioid Use Disorder

United States
Mclean Hospital
National Institute on Drug Abuse (NIDA)

Terminated

A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders

Opioid Use Disorder

United States
Butler Hospital

Withdrawn

Changing Opioid Users' Negative Attitudes Toward Medication Assisted Treatment

Opioid Use Disorder

United States
Dartmouth-Hitchcock Medical Center

Completed

MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence (MySafeRx)

Opioid Use Disorder

United States
Astellas Pharma Global Development, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants

Opioid Use Disorder

United States
Ohio State University

Withdrawn

Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women

Opioid Use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); Laura and John Arnold Foundation

Completed

A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail (SOMATICS FRI)

Opioid Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Opioid Use Disorder

United States
NYU Langone Health

Completed

TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051

Opioid Use Disorder

United States
Alkermes, Inc.

Completed

Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL

Opioid Use Disorder

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA)

Completed

Sex and Female Empowerment (SAFE)

Opioid Use Disorder

United States
Indivior Inc.

Completed

Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

Opioid Use Disorder

United States
Shanna Babalonis, PhD
National Institute on Drug Abuse (NIDA)

Recruiting

Reinforcing Effects of Marijuana and Opioids

Marijuana Use | Opioid Use

United States
Texas Christian University

Recruiting

Preventing Opioid Use Among Justice-involved Youth as They Transition to Adulthood Leveraging Safe Adults (LeSA) (LeSA)

Substance Use | Opioid Use

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Recruiting

Assessing a Clinically-meaningful Opioid Withdrawal Phenotype

Opioid Use Disorder | Opioid Withdrawal | Opioid Craving

United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Completed

Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES)

Opioid Use Disorder | Alcohol Use Disorder

Canada, United States
Howard University
Medical Home Development Group; Geneus Health

Unknown

SMART Brain Health in African-Americans (SMART)

Opioid Use Disorder | Substance Use Disorders | Dopamine Dysregulation Syndrome | African Americans

United States
Delpor, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)

Opiod Use Disorder

Australia
Emory University

Recruiting

Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment (REAL TTIME)

Opioid Use | Opioid Abuse

United States
Wayne State University

Unknown

Does Early Administration of Ultrasound Guided Regional Anesthesia for Long Bone Fractures Effect Long Term Patient Opioid Usage

Opioid Dependence | Opioid Use | Bone Fracture

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Yale University; Clinilabs, Inc.; BioXcel... and other collaborators

Recruiting

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Opioid Use Disorder | Opioid Withdrawal

United States
Weill Medical College of Cornell University
The Institute for Family Health; New York State Health Foundation

Completed

Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients

Opioid-Related Disorders | Opioid Use | Opioid Abuse | Prescription Drug Abuse and Dependency

United States
Howard University
National Institute on Drug Abuse (NIDA); University of Miami; University of Illinois... and other collaborators

Not yet recruiting

Integrating MOUD in African American Community Settings (Better Together)

Opioid Use Disorder

United States
University of Pennsylvania

Recruiting

Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth Intervention

Opioid Use Disorder

United States
Sonara Health

Not yet recruiting

Remotely Observed Methadone Evaluation II (ROME II)

Opioid Use Disorder
Rhode Island Hospital
Brown University

Not yet recruiting

Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose (Optimal Bup)

Opioid Use Disorder

Clinical Trials on Chronic Opioid Use

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations